Abstract
This paper reviews the role of the lipoproteins as risk factors, the metabolic relationship between them and how this contributes to the pathogenesis of atherosclerosis. The conclusion to be drawn is that lipoproteins should not only be considered individually as risk factors but also as part of a dynamic system whereby metabolic products of lipoproteins may be atherogenic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zilversmit, D.B. Circulation 60: 473–485, 1979
Goldstein, J.L. and Brown, M.S. Ann. Rev. of Biochem. 46: 897–930, 1977
Glomset, J.A. J. Lipid Res. 9: 115–167, 1968
Barr, D.P., Russ, E.M., and Eder, H.A. Amer. J. Med. 11: 480–493, 1951
Miller, G.J. and Miller, N.E. Lancet i, 16–19, 1971
Castelli, W.P., Doyle, J.T., Gordon, T., James, C.G., Hjortland, M.C., Hulley, S.B., Kagan, A., and Zukel, W.J. Circulation 5: 767–772, 1977
Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B. and Dawber, T.R. Amer. J. Med. 62: 707–714, 1977
Gidez, L.I., Miller, G.J., Burstein, M. and Eder, H.A. In Report of the HDL Methodology Workshop N.I.H. Publication N9. 79:1661, 1979.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Eder, H.A. (1985). Lipoproteins as Risk Factor. In: Halpern, M.J. (eds) Lipid Metabolism and Its Pathology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2445-4_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2445-4_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9486-3
Online ISBN: 978-1-4613-2445-4
eBook Packages: Springer Book Archive